Chonluten Peptide

Bronchial mucosa bioregulatory tripeptide (Thr-Glu-Asp). Researched for respiratory immune modulation and mucosal epithelium normalization.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUCHON-001
SequenceThr-Glu-Asp
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Chonluten (Thr-Glu-Asp)?

Bronchial mucosa tripeptide bioregulator that modulates respiratory immune responses. Research shows it normalizes local IgA secretion, mucosal T-cell populations, and cytokine balance in the bronchial associated lymphoid tissue (BALT).

Frequently Asked Questions

Chonluten vs Bronchogen?

Bronchogen (AEDL) targets respiratory epithelial structure and mucociliary function. Chonluten (TED) targets the mucosal immune system (IgA, BALT). They are complementary — one for structural, one for immune aspects.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.